• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Integrated Rehabilitation Reduces Post-Stroke Anxiety in Multicenter Randomized Controlled Trial

by
November 14, 2026
in Health
Reading Time: 6 mins read
0
Integrated Rehabilitation Reduces Post-Stroke Anxiety in Multicenter Randomized Controlled Trial

Integrated Rehabilitation Reduces Post-Stroke Anxiety in Multicenter Randomized Controlled Trial

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A prospective multicenter randomized controlled trial evaluating 188 adult patients has revealed that augmenting standard post-stroke medical care with a structured four-week integrated rehabilitation program combining repetitive transcranial magnetic stimulation, specialized acupuncture, and traditional Chinese herbal medicine produces significantly greater reductions in post-stroke anxiety than conventional therapy alone. Conducted across four hospital centers in China, the clinical trial assigned eligible participants in a balanced one-to-one ratio to either standard care consisting of pharmacotherapy, general nursing support, and structured physical exercise rehabilitation or to the multimodal intervention program incorporating all three complementary modalities alongside standard care. Primary efficacy evaluations conducted at the conclusion of the active four-week treatment period revealed that participants allocated to the integrated rehabilitation group achieved a statistically significant 2.489-point greater reduction on the clinician-rated Hamilton Anxiety Rating Scale than those receiving standard care alone. Long-term longitudinal follow-up evaluations demonstrated that this therapeutic advantage was reliably maintained eight weeks after completing the active intervention, confirming sustained symptom reduction through week 12.

Post-stroke anxiety represents an exceptionally prevalent and debilitating affective complication following cerebrovascular accidents, affecting approximately 18 to 25 percent of stroke survivors worldwide and occurring in an estimated 29.3 percent of patients within the first year of recovery. Clinical investigations cited by the study team indicate that younger and middle-aged stroke survivors between 18 and 55 years of age experience an especially elevated vulnerability, with post-stroke anxiety prevalence rates reaching as high as 39 percent. Beyond generating severe emotional distress and diminishing subjective quality of life, post-stroke anxiety actively impedes physical rehabilitation, accelerates cognitive decline, and exposes vulnerable patients to substantially higher risks of recurrent stroke, enduring functional disability, and early mortality. Despite the substantial disease burden, international clinical practice lacks standardized therapeutic consensus guidelines, leaving clinicians to assemble disparate empirical combinations of psychotropic medications, psychological counseling, and motor rehabilitation. Furthermore, standard pharmacological agents, such as conventional antidepressants and anxiolytics, frequently cause problematic central nervous system and gastrointestinal side effects, highlighting an urgent necessity for evidence-based multimodal strategies.

To address this therapeutic gap, researchers designed a rigorous prospective, multicenter, randomized controlled clinical trial conducted in accordance with the Consolidated Standards of Reporting Trials and the Standards for Reporting Interventions in Clinical Trials of Acupuncture guidelines. The clinical investigation took place across four distinct hospital centers in China: The Third Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang General Hospital of the Armed Police, Hangzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, and The Second Hospital of Jinhua. The overarching trial protocol received formal institutional review board approvals from the ethics committees of all four participating clinical institutions and was registered in the ClinicalTrials.gov public registry under the identifier NCT05147077. Participants were randomized using a central computerized allocation system to guarantee balanced group distribution. Although the physical procedures of acupuncture and transcranial stimulation prevented blinding of participating patients and administering clinicians, the trial maintained rigorous assessor blinding, ensuring that all outcome assessors and study biostatisticians remained completely masked to treatment allocation throughout the entire twelve-week study period.

The clinical trial enrolled a total of 188 patients between 25 and 85 years of age who had experienced their first verified episode of cerebral infarction or intracerebral hemorrhage diagnosed under standard national clinical practice criteria. All participants met validated diagnostic criteria for post-stroke anxiety, demonstrating anxiety symptoms that arose in a clear temporal sequence following the initial cerebrovascular insult. Eligible participants exhibited mild-to-moderate anxiety severity, defined by baseline scores between 7 and 21 on the Hamilton Anxiety Rating Scale, with post-stroke disease duration spanning from two weeks to 36 months. Under traditional Chinese medicine diagnostic frameworks, all enrolled patients presented with the specific syndrome differentiation pattern of liver stagnation transforming into fire. Baseline motor and functional eligibility criteria mandated a Barthel Index score above 20 and a Fugl-Meyer Assessment score between 0 and 95, alongside clear consciousness and intact comprehension. The trial excluded individuals presenting with acute head trauma, intracranial infections, brain tumors, implanted metallic or electronic devices, seizure disorders, severe organ complications, or baseline cognitive impairment.

Participants assigned to the control group received an individualized standard care regimen developed in alignment with the Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders and stroke rehabilitation. Standard pharmacotherapy centered on anxiolytic management utilizing the selective serotonin reuptake inhibitor escitalopram oxalate, prescribed at a fixed dose of 10 milligrams once daily for four weeks, with additional secondary prevention medications such as antihypertensive, lipid-lowering, and cerebrovascular drugs administered according to individual patient indications. Nursing personnel conducted regular general care assessments to monitor each patient’s overall physical status, psychological well-being, and family support structure. Concurrently, certified physical therapists delivered individualized exercise therapy sessions lasting 30 to 45 minutes once daily, five days per week, over the four-week period. These therapeutic sessions incorporated specialized limb positioning, passive and active joint mobilization, targeted muscle massage on the paretic side, progressive muscle strengthening, sitting and standing balance retraining, and comprehensive gait re-education to optimize functional motor recovery.

Participants randomized to the integrated rehabilitation group received identical baseline standard care combined with twenty structured sessions of repetitive transcranial magnetic stimulation, twenty comprehensive acupuncture treatments, and daily traditional Chinese herbal medicine across the four-week intervention period. Transcranial magnetic stimulation was administered five days weekly using a CCY-I magnetic field stimulator, delivering 900 pulses of continuous 1-hertz low-frequency stimulation over the right dorsolateral prefrontal cortex at 90 percent of the resting motor threshold during 15-minute daily sessions. Concurrently, qualified acupuncturists administered standardized acupuncture five times weekly, beginning with scalp needling across forehead and vertex points retained for 60 minutes, followed by body acupuncture at Yintang, Danzhong, and bilateral Taichong, Xingjian, Shenmen, Tongli, and Neiguan retained for 30 minutes, with manual manipulation applied to achieve the de qi sensation. Additionally, participants consumed Danzhixiaoyao Powder twice daily, a customized herbal decoction containing Danpi, fried Zhizi, Danggui, Baishao, fried Chaihu, Fuling, fried Baizhu, and roasted Gancao designed to clear internal heat and soothe liver stagnation.

The primary efficacy analysis, conducted under an intention-to-treat framework using repeated-measures general linear modeling, demonstrated a pronounced and statistically significant therapeutic benefit favoring the integrated rehabilitation approach. Over the four-week intervention period, patients receiving the integrated package exhibited a 2.489-point greater reduction in Hamilton Anxiety Rating Scale scores than those receiving standard care alone, supported by a 95 percent confidence interval ranging from 1.500 to 3.479 points and a partial eta-squared effect size of 0.117. Longitudinal repeated-measures analysis of variance across baseline, week 4, and week 12 revealed a significant time-by-group interaction alongside significant main effects for both time and treatment group. While post-hoc within-group comparisons confirmed that participants in both study arms achieved statistically significant anxiety reductions at week 4 and week 12, between-group comparisons demonstrated that the integrated rehabilitation cohort achieved significantly lower absolute anxiety scores at the conclusion of treatment and maintained a significant 2.383-point score advantage through week 12. Complete-case sensitivity analyses confirmed identical statistical conclusions.

Supportive analyses of secondary clinical outcomes demonstrated broad-ranging benefits across emotional, cognitive, and functional domains, reinforcing the primary anxiety findings. On the patient-reported Self-Rating Anxiety Scale, participants in the integrated rehabilitation group achieved a 2.447-point greater reduction from baseline to week 4 compared with standard care, demonstrating strong convergence between subjective self-report and clinician-rated outcomes. To account for multiplicity across the seven secondary outcomes, investigators conducted a post-hoc Holm-Bonferroni adjustment on all secondary interaction tests. Following this stringent correction, group-by-time interaction effects remained statistically significant for the Pittsburgh Sleep Quality Index, Montreal Cognitive Assessment, upper-extremity Fugl-Meyer Assessment, and basic Activities of Daily Living. Patients receiving integrated rehabilitation exhibited significantly higher cognitive scores on the Montreal Cognitive Assessment and superior motor improvements in the upper extremities at week 4. In contrast, interaction effects for Instrumental Activities of Daily Living did not reach statistical significance after Holm adjustment, and lower-extremity motor scores showed no significant between-group divergence.

Safety evaluations conducted throughout the clinical trial documented excellent overall treatment tolerability, with no serious adverse events, intervention-related hospitalizations, or study discontinuations resulting from safety concerns in either study cohort. Across all 188 enrolled participants, investigators recorded only six mild adverse events during the initial two weeks of the intervention phase, all of which resolved spontaneously during routine follow-up without requiring medical intervention, treatment interruption, or medication dosage adjustments. In the standard care group, four adverse events were observed, including two reports of headache, one case of irritability, and one instance of decreased appetite, all classified as known potential reactions to escitalopram oxalate pharmacotherapy. Within the integrated rehabilitation group, two adverse events occurred, consisting of one report of irritability and one report of mild nausea. Full study retention was achieved in the integrated rehabilitation group with zero dropouts, while two participants in the standard care group were lost or voluntarily withdrew during the post-treatment follow-up period.

While these clinical trial findings provide compelling preliminary evidence supporting integrated multimodal rehabilitation as an adjunct to conventional medical management for post-stroke anxiety, the study investigators outlined several important methodological limitations and interpretive considerations. Most notably, because the trial evaluated the combined rehabilitation package as a unified intervention against standard care, the current data cannot isolate the specific therapeutic contributions of transcranial magnetic stimulation, acupuncture, or herbal medicine individually, nor determine whether their clinical actions operate through additive or synergistic mechanisms. Furthermore, the absence of sham-controlled procedures introduces potential non-specific therapeutic influences, while the lack of biological markers, neuroendocrine measurements, or neuroimaging data leaves underlying physiological mechanisms unverified. Finally, because all participants were recruited from specialized clinical centers in China under specific traditional Chinese medicine diagnostic criteria, the generalizability of these therapeutic findings to international healthcare systems remains uncertain, emphasizing the necessity for future dismantling trials incorporating extended observation periods, formal cost-effectiveness analyses, and objective neurobiological assessments.

Subject of Research: Multimodal integrated rehabilitation for post-stroke anxiety

Article Title: Integrated rehabilitation for post-stroke anxiety: a prospective, multicenter, randomized controlled trial

Article References: Xu, S., Ye, K., Zhang, S., Chen, K., Zhou, J., Hu, X., Li, L., Zhang, Z., & Gao, H. (2026). Integrated rehabilitation for post-stroke anxiety: a prospective, multicenter, randomized controlled trial. Frontiers in Psychiatry, 17, Article 1985948. https://doi.org/10.3389/fpsyt.2026.1985948

Image Credits: AI Generated

DOI: 10.3389/fpsyt.2026.1985948

Keywords: post-stroke anxiety, repetitive transcranial magnetic stimulation, acupuncture, Chinese herbal medicine, Danzhixiaoyao Powder, Hamilton Anxiety Rating Scale, randomized controlled trial, stroke rehabilitation, escitalopram, cerebral infarction, intracerebral hemorrhage, Fugl-Meyer Assessment, Montreal Cognitive Assessment, Pittsburgh Sleep Quality Index, Activities of Daily Living, Self-Rating Anxiety Scale

News Source: Glenn Wilkins. (November 14, 2026). Integrated Rehabilitation Reduces Post-Stroke Anxiety in Multicenter Randomized Controlled Trial. Scienmag.

Tags: activities of daily livingacupuncturecerebral infarctionChinese herbal medicineDanzhixiaoyao PowderescitalopramFugl-Meyer AssessmentHamilton Anxiety Rating Scaleintracerebral hemorrhageMontreal Cognitive AssessmentPittsburgh Sleep Quality Indexpost-stroke anxietyrandomized controlled trialrepetitive transcranial magnetic stimulationSelf-Rating Anxiety Scalestroke rehabilitation
Share12Tweet7Share2ShareShareShare1

Related Posts

Muscle Oxidative Capacity Drops by Half in Children with Cerebral Palsy

Muscle Oxidative Capacity Drops by Half in Children with Cerebral Palsy

November 17, 2026
Global Health Worker Migration Requires Competency Benchmarking Beyond Qualification Recognition

Global Health Worker Migration Requires Competency Benchmarking Beyond Qualification Recognition

November 17, 2026

Machine Learning Identifies Divergent Progression Rates in Early Knee Osteoarthritis Phenotypes

November 17, 2026

Scoping Review Analyzes Health Coaching Delivery and Core Gaps in Pregnancy

November 17, 2026

POPULAR NEWS

  • Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    29 shares
    Share 12 Tweet 7
  • Veterinarians Identify Twelve Defences to Improve Medication Safety in Sows

    29 shares
    Share 12 Tweet 7
  • Ascending Aorta Shows Marked Elongation Before Dissection Despite Only Moderate Dilatation

    29 shares
    Share 12 Tweet 7
  • Rural Australian Hospital Study Links Insulin and Polypharmacy to Medication Readmissions

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Muscle Oxidative Capacity Drops by Half in Children with Cerebral Palsy

Global Health Worker Migration Requires Competency Benchmarking Beyond Qualification Recognition

Planets and Stars Set New Limits on Dark Matter Electromagnetic Properties

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.